Skip to content

Common Stock at other companies

Eli Lilly logo
Eli LillyLLY
$590M-0.4%
Oric Pharmaceuticals, Inc. logo
Oric Pharmaceuticals, Inc.ORIC
$11K+57.1%
Opko Health logo
Opko HealthOPK
$7.85M+11.9%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$6K+20.0%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
120M0.0%
Immunome logo
ImmunomeIMNM
$11K+22.2%

Other financials

Income statement

See full
Operating income-$58.0M-66.3%
Net income-$53.1M-74.7%
EPS (diluted)-$0.52-44.4%

Balance sheet

See full
Cash & equivalents$52.5M+3.8%
Total debt$956.0K-16.7%
Total equity$480.5M+25.3%
Total assets$530.6M+29.5%

Cash flow

See full
Operating cash flow-$46.0M-4.6%
CapEx-
Free cash flow-$34.5M-27.8%

Valuation

See full
Market cap$998.38M+253%
Enterprise value$946.79M+306%

Returns & leverage

See full
Return on equity-42.9%+1.3pp
Debt / equity0.0×
Current ratio10.9×-4.3×

Where this comes from

Reported directly by Olema Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: Olema Pharmaceuticals, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Olema Pharmaceuticals, Inc.'s common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Olema Pharmaceuticals, Inc.'s common stock?
Olema Pharmaceuticals, Inc. (OLMA) reported common stock of $8K in Q1 2026.
How has Olema Pharmaceuticals, Inc.'s common stock changed year-over-year?
Olema Pharmaceuticals, Inc.'s common stock increased by 14.3% year-over-year, from $7K to $8K.
What is the long-term trend for Olema Pharmaceuticals, Inc.'s common stock?
Over 5 years (2020 to 2025), Olema Pharmaceuticals, Inc.'s common stock has grown at a 21.7% compound annual growth rate (CAGR), from $3K to $8K.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).